Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000974

Drug Information
NamePhenylbutazone    
SynonymsKBio2_004127; Alqoverin; Artrizone; Fenibutazona; SPECTRUM1500482; Scanbutazone; Ipsoflame; MolPort-001-783-564; Novophenyl; AZOLID (TN); Butaphen; Fenylbutazon; Buvetzone; Bute, Butazolidin, Butatron, Phenylbutazone; Butylpyrin; Buzon; esteve; Fenibutal; DivK1c_000331; Robizone; component of Azolid-A; Zolidinum; HMS2091P08; Butartril; B.T.Z; Diozol; CHEBI:48574; G 13871; Rectofasa; NCGC00015846-01; Bunetzone; Phenyl-Mobuzon; 3,5-Dioxo-1,2-diphenyl-4-n-butyl-pyrazolidin; NCGC00023855-05; fe nilbutine; Butartrina; Phenyzone; Lopac-P-8386; art rizin; Tetnor; Fenartil; 4-Butyl-1,2-diphenyl-3,5-pyrazolidinedione; Butadiona; NCI-C55414; HMS1920H06; Chembutazone; Butone; Intrabutazone; 1,2-Diphenyl-4-butyl-3,5-dioxopyrazolidine; NCGC00015846-06; Fenibutasan; Lopac0_000993; 1,2-Diphenyl-2,3-dioxo-4-N-butylpyrazoline; KBioSS_001559; Antadol; Reumuzol; D010653; EINECS 200-029-0; Butagesic; NCGC00023855-04; R-3-ZON; D00510; 1,2-Diphenyl-3,5-dioxo-4-butylpyrazolidine; Malgesic; Azolid; CCRIS 2374; Rubatone; CHEMBL101; Reumune; C07440; P8386_SIGMA; 3,5-dioxo-4-butyl-1-diphenyl-pyrazolidine; Usaf ge-15; Fenibutol; HSDB 3159; Alka Butazolidin; Lingel; Phen-Buta-Vet; 50-33-9; Intrazone; NSC25134; Schemergen; Butaluy; Schemergin; WLN: T5VNNV EHJ BR& CR& E4; 4297-92-1; Azobutyl; Fenilbutina; Reumazol; Reumasyl; 'Esteve'; Febuzina; Robizon-V; Oprea1_416494; Fenilbutazone; DB08343; Butatron; 4-Butyl-1,2 -diphenyl-3,5-dioxo pyrazolidine; Butacote; KBioGR_000954; MLS001148412; Azdid; Alindor; Buta phen; Benzone; Spectrum4_000477; B.t.z.; NCGC00015846-12; Pyrabutol; Mephabutazon; 4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione; VAC-10; MLS000069424; Tencodyne; UNII-GN5P7K3T8S; SMR000059073; Reumazin; Uzone; Bio-0693; KBio3_001589; NCGC00023855-07; MLS002152929; Butapyrazole; Bute; butyl pyrin; Apo-Phenylbutazone; Butalgina; P1686; Todalgil; Fenilbutazona [INN-Spanish]; butadione; Phenbutazol; P 8386; Artizin; Phenylbutazon; Ticinil; Butidiona; Flexazone; Phenopyrine; Zolaphen; Reudo; Bizolin; Spectrum5_001335; Mepha-Butazon; S1654_Selleck; 3,5-Dioxo-1,2-diphenyl-4-N-butylpyrazolidine; Phebuzin; Spectrum_001079; Butazolidine; Ia-But; Fenilbutazone [DCIT]; Tevcodyne; IDI1_000331; Fenotone; AC-683; Phenylbutazonum [INN-Latin]; Busone; STK388348; Phebuzine; Elmedal; SR-01000000004-4; Ecobutazone; KBio2_006695; Intalbut; NINDS_000331; NCGC00023855-06; SPBio_001283; 3,5-Pyrazolidinedione, 4-butyl-1,2-diphenyl-; AC1L1IXW; Robizone-V; Bizolin 200; Digibutina; Butapirazol; 1,2-diphenyl-3,5-dioxo-4-n-butylpyrazoline; Butazina; Fenilidina; 4-Butyl-1,2-diphenylpyrazolidine-3,5-dione; Butazolidin; Arthrizon; Butadion; Equi bute; HMS2090H17; 4-Butyl-1,2-diphenyl-3,5-dioxo pyrazolidine; Shigrodin; BSPBio_002369; Reudox; Phenylbutazone [USAN:INN:BAN:JAN]; UNM000001255503; LS-71; Pyrazolidin; Therazone; Kadol; nchembio.128-comp31; Anerval; Praecirheumin; Butacompren; Tazone; Butarecbon; Diphenylbutazone; Butoz; Alkabutazona; 4-Butyl-1,2-diphenyl-3,5-dioxopyrazolidine; Neo-zoline; NCGC00023855-03; Merizone; Phenbutazone; Phenylbutazon [German]; AC1Q2VLE; KBio1_000331; NSC 25134; CID4781; 3,5-Dioxe-4 buty-1, diphenyl-pyrazolidine; Fenilbutazona; Fenilbutazon; Nadozone; Phenyl butazone; Phenyzene; HMS501A13; Equipalazone; Phenylbutaz; AKOS001592731; NCI-C56531; NCGC00015846-02; Reupolar; Anpuzone; 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE; Artropan; NCGC00181112-01; Wescozone; Butiwas-Simple; BRN 0290080; phenylbutazone; DB00812; DA-192; A 7514; Diphebuzol; G 13,871; Spectrum2_001282; NCGC00023855-08; Artrizin; Butadionum; Equiphen; I01-0883; Fenilbutine; Butazona; Phenylbutazonum; Butalidon; EU-0100993; Phenylbutazone (JP15/USP/INN); Betazed; Cotylbutazone; Butapirazole; Spectrum3_000675; Nadazone; P1Z; KBio2_001559; Anuspiramin; Pirarreumol "B"; Eributazone; Exrheudon N; Diossidone; Mephabutazone; 1,2-Diphenyl-4-butyl-3,5-pyrazolidinedione; Pirarreumol B    
IndicationChronic painApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAnalgesics    
CAS NumberCAS 50-33-9
FormularC19H20N2O2    
PubChem Compound IDCID 4781.    
PubChem Substance IDSID 9644.    
SuperDrug ATC IDM01AA01;    
SuperDrug CAS ID000050339;    
TargetCOX-2Inhibitor[2]
Ref 1Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis. Expert Opin Emerg Drugs. 2007 May;12(2):229-52. To Reference
Ref 2COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis. Pharmacol Res. 2005 Oct;52(4):302-6. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543